Chestnut Hill, MA, United States of America

Doron Lipson

USPTO Granted Patents = 32 (Patent Applications = 34)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 12 (Patent Applications = 12)

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 403(Granted Patents)

Location History:

Tel Aviv, IL (2012)
Haifa, IL (2008 - 2013)
Rehovot, IL (2015)
Newton, MA (US) (2021)
Chestnut Hill, MA (US) (2014 - 2023)
Cambridge, MA (US) (2021 - 2024)

Company Filing History:

21 out of 39

Foundation Medicine, Inc.

patents

6 out of 1,046

Bio-rad Laboratories, Inc.

Integrated Dna Technologies, Inc.

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378302 - Fusion molecules and uses thereof (2025-08-05),

2. 12274699 - Methods of treating cholangiocarcinoma (2025-04-14),

3. 12239648 - KIF5B-RET fusion molecules and uses thereof (2025-03-04),

4. 12180540 - Optimization of multigene analysis of tumor samples (2024-12-31),

5. 12116638 - Estrogen receptor mutations and uses thereof (2024-10-15),

6. 11959141 - Multigene analysis of tumor samples (2024-04-16),

7. 11771698 - Methods of treating cholangiocarcinoma (2023-10-03),

8. 11674962 - Therapeutic and diagnostic methods for cancer (2023-06-13),

9. 11578372 - NTRK1 fusion molecules and uses thereof (2023-02-14),

10. 11566282 - T-enhanced blocking oligonucleotides and baits for improved target enrichment and reduced off-target selection (2023-01-31),

11. 11421265 - Optimization of multigene analysis of tumor samples (2022-08-23),

12. 11286532 - Estrogen receptor mutations and uses thereof (2022-03-29),

13. 11230589 - Fusion molecules and uses thereof (2022-01-25),

14. 11142800 - Biomarkers of cancer (2021-10-12),

15. 11136619 - Optimization of multigene analysis of tumor samples (2021-10-05),

Title: The Innovative Journey of Inventor Doron Lipson

Introduction:

Doron Lipson, a renowned inventor based in Chestnut Hill, MA (US), has made significant contributions to the field of multi-gene analysis and methods for treating cholangiocarcinoma. With an impressive portfolio of 26 patents, Lipson continues to push the boundaries of innovation in the medical research domain.

Latest Patents:

1. Multigene analysis of tumor samples: Lipson's patent revolves around methods of evaluating or providing a clonal profile of a subject interval, especially in the context of tumor samples. This innovation aids in understanding genomic complexities associated with cancer.

2. Methods of treating cholangiocarcinoma: Another patent by Lipson focuses on developing novel methods and compositions for effectively treating cholangiocarcinoma, showcasing his commitment to advancing cancer therapies.

Career Highlights:

Lipson has held key positions at esteemed companies such as Foundation Medicine, Inc. and Bio-Rad Laboratories, Inc., where he has played a pivotal role in driving research and development efforts. His expertise in genomics and oncology has been instrumental in shaping cutting-edge solutions for the medical community.

Collaborations:

Throughout his career, Lipson has collaborated with industry experts such as Philip James Stephens and Roman Yelensky, fostering a culture of innovation and knowledge-sharing. These collaborative efforts have led to groundbreaking discoveries in the field of precision medicine.

Conclusion:

In conclusion, Doron Lipson's unwavering dedication to innovation and his remarkable contributions to the healthcare industry underscore his status as a trailblazing inventor. His pioneering work in multi-gene analysis and cancer treatment methodologies continues to inspire and shape the landscape of medical research.

This text is generated by artificial intelligence and may not be accurate.